Volume 23, Issue 152 (2-2017)                   RJMS 2017, 23(152): 65-76 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nasiripour 1, Farasatinasab M, Khodaverdi 3. Premature Ejaculation Management. RJMS. 2017; 23 (152) :65-76
URL: http://rjms.iums.ac.ir/article-1-4202-en.html
Iran University of Medical Sciences, Tehran, Iran , maryfarasati@gmail.com
Abstract:   (5321 Views)

Male sexual disorder includes hypoactive sexual desire disorder, male erectile disorder, premature ejaculation and male orgasmic disorder. Premature ejaculation is the most common problem. Premature ejaculation could have an effect on the various aspects of the quality of life including emotional happiness, interpersonal relationship, and social behavior. One of the important aspects of premature ejaculation is definition of this problem and explanation to the individuals. Currently, various treatments are available for premature ejaculation consistent with psychological/behavioral management and pharmacotherapy. Serotonin Specific Reuptake Inhibitors (SSRIs) especially dapoxitin, are first-line pharmacotherapy; however tramadol might be used for unresponsive premature ejaculation. New therapeutic approaches are being researched including modafinil, botulinum toxin, acupuncture and circumcision.

Full-Text [PDF 257 kb]   (15216 Downloads)    
Type of Study: review article | Subject: Pharmacy

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2021 All Rights Reserved | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb